• +1-646-491-9876
    • +91-20-67278686

    Search

    Left Ventricular Dysfunction - Pipeline Review, H1 2017

    Left Ventricular Dysfunction - Pipeline Review, H1 2017

    • Report Code ID: RW0001689422
    • Category Healthcare
    • No. of Pages 62
    • Publication Month Feb-17
    • Publisher Name Global Markets Direct
    Report Summary

    Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides an overview of the Left Ventricular Dysfunction (Cardiovascular) pipeline landscape.

    Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism and coronary artery disease.

    Report Highlights

    Publisher's Pharmaceutical and Healthcare latest pipeline guide Left Ventricular Dysfunction - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Left Ventricular Dysfunction (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

    The Left Ventricular Dysfunction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Left Ventricular Dysfunction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 7 and 2 respectively.

    Left Ventricular Dysfunction (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

    Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

    Report Scope

    - The pipeline guide provides a snapshot of the global therapeutic landscape of Left Ventricular Dysfunction (Cardiovascular).
    - The pipeline guide reviews pipeline therapeutics for Left Ventricular Dysfunction (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
    - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
    - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
    - The pipeline guide reviews key companies involved in Left Ventricular Dysfunction (Cardiovascular) therapeutics and enlists all their major and minor projects.
    - The pipeline guide evaluates Left Ventricular Dysfunction (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
    - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
    - The pipeline guide reviews latest news related to pipeline therapeutics for Left Ventricular Dysfunction (Cardiovascular)

    Reasons to buy

    - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
    - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
    - Find and recognize significant and varied types of therapeutics under development for Left Ventricular Dysfunction (Cardiovascular).
    - Classify potential new clients or partners in the target demographic.
    - Develop tactical initiatives by understanding the focus areas of leading companies.
    - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
    - Formulate corrective measures for pipeline projects by understanding Left Ventricular Dysfunction (Cardiovascular) pipeline depth and focus of Indication therapeutics.
    - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
    - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
    Table of Contents
    List of Tables
    List of Figures
    Introduction
    Publisher Report Coverage
    Left Ventricular Dysfunction - Overview
    Left Ventricular Dysfunction - Therapeutics Development
    Pipeline Overview
    Pipeline by Companies
    Products under Development by Companies
    Left Ventricular Dysfunction - Companies Involved in Therapeutics Development
    Amgen Inc
    Bayer AG
    Capricor Therapeutics Inc
    F. Hoffmann-La Roche Ltd
    Innopharmax Inc
    Les Laboratoires Servier SAS
    Quantum Genomics SA
    RedHill Biopharma Ltd
    TiGenix NV
    Left Ventricular Dysfunction - Therapeutics Assessment
    Assessment by Target
    Assessment by Mechanism of Action
    Assessment by Route of Administration
    Assessment by Molecule Type
    Left Ventricular Dysfunction - Drug Profiles
    BAY-1142524 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CAP-1001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CAP-1002 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    carvedilol CR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    carvedilol phosphate CR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    CTX-101 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    NP-202 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    omecamtiv mecarbil MR - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    pirfenidone - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    QGC-001 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    S-38844 - Drug Profile
    Product Description
    Mechanism Of Action
    R&D Progress
    Left Ventricular Dysfunction - Dormant Projects
    Left Ventricular Dysfunction - Discontinued Products
    Left Ventricular Dysfunction - Product Development Milestones
    Featured News & Press Releases
    Aug 27, 2013: Amgen to Highlight New Data at Upcoming ESC Congress 2013
    Jun 18, 2013: Cytokinetics Announces Presentation Of Results From Phase IIb Clinical Trial Of Omecamtiv Mecarbil At ESC Congress 2013
    Feb 19, 2013: RedHill Biopharma Announces Notice Of Allowance From US Patent And Trademark Office For Cardio Drug RHB-101
    Appendix
    Methodology
    Coverage
    Secondary Research
    Primary Research
    Expert Panel Validation
    Contact Us
    Disclaimer

    List of Tables

    Number of Products under Development for Left Ventricular Dysfunction, H1 2017
    Number of Products under Development by Companies, H1 2017
    Products under Development by Companies, H1 2017
    Left Ventricular Dysfunction - Pipeline by Amgen Inc, H1 2017
    Left Ventricular Dysfunction - Pipeline by Bayer AG, H1 2017
    Left Ventricular Dysfunction - Pipeline by Capricor Therapeutics Inc, H1 2017
    Left Ventricular Dysfunction - Pipeline by F. Hoffmann-La Roche Ltd, H1 2017
    Left Ventricular Dysfunction - Pipeline by Innopharmax Inc, H1 2017
    Left Ventricular Dysfunction - Pipeline by Les Laboratoires Servier SAS, H1 2017
    Left Ventricular Dysfunction - Pipeline by Quantum Genomics SA, H1 2017
    Left Ventricular Dysfunction - Pipeline by RedHill Biopharma Ltd, H1 2017
    Left Ventricular Dysfunction - Pipeline by TiGenix NV, H1 2017
    Number of Products by Stage and Target, H1 2017
    Number of Products by Stage and Mechanism of Action, H1 2017
    Number of Products by Stage and Route of Administration, H1 2017
    Number of Products by Stage and Molecule Type, H1 2017
    Left Ventricular Dysfunction - Dormant Projects, H1 2017
    Left Ventricular Dysfunction - Discontinued Products, H1 2017

    List of Figures

    Number of Products under Development for Left Ventricular Dysfunction, H1 2017
    Number of Products under Development by Companies, H1 2017
    Number of Products by Top 10 Targets, H1 2017
    Number of Products by Stage and Top 10 Targets, H1 2017
    Number of Products by Top 10 Mechanism of Actions, H1 2017
    Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017
    Number of Products by Routes of Administration, H1 2017
    Number of Products by Stage and Routes of Administration, H1 2017
    Number of Products by Molecule Types, H1 2017
    Number of Products by Stage and Top 10 Molecule Types, H1 2017
    Amgen Inc
    Bayer AG
    Capricor Therapeutics Inc
    F. Hoffmann-La Roche Ltd
    Innopharmax Inc
    Les Laboratoires Servier SAS
    Quantum Genomics SA
    RedHill Biopharma Ltd
    TiGenix NV

    Request for Sample

    Report Url http://www.reportsweb.com//left-ventricular-dysfunction-pipeline-review-h1-2017&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url http://www.reportsweb.com//left-ventricular-dysfunction-pipeline-review-h1-2017&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url http://www.reportsweb.com//left-ventricular-dysfunction-pipeline-review-h1-2017&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments